Clinical trial
A Randomized Phase II Trial of Oral Topotecan Given Twice a Day for 5 Days or Once a Day for 10 Days to Patients With Myelodysplastic Syndromes (MDS)
NCT00003675 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase II Trial of Oral Topotecan Given Twice a Day for 5 Days or Once a Day for 10 Days to Patients With Myelodysplastic Syndromes (MDS)
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 1999
- Completion date
- April 30, 2009
- Enrollment
- 100 (actual)
- Sites
- 48
Conditions
As the registry lists them; a condition with its own page is linked.